Literature DB >> 29982111

Effects of exercise training on cytokines and adipokines in multiple Sclerosis: A systematic review.

Raoof Negaresh1, Robert W Motl2, Motahare Mokhtarzade3, Ulrik Dalgas4, Darpan Patel5, Mehdieh Molanouri Shamsi1, Nastaran Majdinasab6, Rouholah Ranjbar7, Philipp Zimmer8, Julien S Baker9.   

Abstract

BACKGROUND: Physical activity, particularly exercise training, is an evidence-based approach for managing symptoms, restoring function and improving overall wellness in people with multiple sclerosis (MS). Several recent studies have argued for a potential disease modifying effect of exercise in people with MS, and among the potential mediating mechanisms are exercise training effects on both cytokines and adipokines. The objectives of this study were to perform a systematic review of exercise training effects on cytokine and adipokine profiles in persons with MS.
METHODS: We conducted open-dated searches of PubMed, Cochrane Library, EMBASE and PEDro using the terms 'Multiple sclerosis' or 'MS' AND 'exercise' OR 'training' OR 'physical activity' AND 'cytokine' OR 'inflammatory' OR 'immune' OR 'adipokine'. Included studies were written in English; comprised of humans with MS, and evaluated the effects of regular physical activity or exercise on pro-inflammatory, anti-inflammatory cytokines or adipokines. Two authors independently scanned titles and abstracts, and read the studies included. All studies were rated on the PEDro scale and further classified based on American Academy of Neurology criteria.
RESULTS: Twelve studies were included of which 10 studies focused on cytokines, 1 study focused on adipokines, and 1 study included both cytokines and adipokines. The selected studies included 3 Class I studies, 7 Class II studies, and 2 Class IV studies and had average PEDro scores of 6.9 ± 1.6. Studies included endurance (n = 5), resistance (n = 3), combined (n = 3), and vibration (n = 1) training. Overall, there is a general lack of standardization of procedures across studies and inconsistent evidence for the effects of physical activity and exercise on cytokine and adipokine profiles in MS, with a general pattern indicating a lack of effect.
CONCLUSION: Research regarding the effects of exercise training on cytokines and adipokines in MS is in its infancy, but exercise represents an adjuvant therapy in MS, and future studies are essential for clarifying the role of exercise on cytokines and adipokines in MS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipokine; Cytokine; Demyelination; Exercise; Multiple sclerosis

Mesh:

Substances:

Year:  2018        PMID: 29982111     DOI: 10.1016/j.msard.2018.06.008

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  11 in total

Review 1.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

2.  Cytokine Profile in Patients with Multiple Sclerosis Following Exercise: A Systematic Review of Randomized Clinical Trials.

Authors:  Parisa Najafi; Maryam Hadizadeh; Jadeera Phaik Geok Cheong; Hamidreza Mohafez; Suhailah Abdullah
Journal:  Int J Environ Res Public Health       Date:  2022-07-02       Impact factor: 4.614

Review 3.  Can Operant Conditioning of EMG-Evoked Responses Help to Target Corticospinal Plasticity for Improving Motor Function in People With Multiple Sclerosis?

Authors:  Aiko K Thompson; Thomas Sinkjær
Journal:  Front Neurol       Date:  2020-07-15       Impact factor: 4.003

Review 4.  Impact of acute exercise on immediate and following early post-exercise FGF-21 concentration in adults: systematic review and meta-analysis.

Authors:  Mousa Khalafi; Karim Azali Alamdari; Michael E Symonds; Hadi Nobari; Jorge Carlos-Vivas
Journal:  Hormones (Athens)       Date:  2020-11-05       Impact factor: 2.885

5.  A Critical Systematic Review of Current Evidence on the Effects of Physical Exercise on Whole/Regional Grey Matter Brain Volume in Populations at Risk of Neurodegeneration.

Authors:  Lars G Hvid; Dylan L Harwood; Simon F Eskildsen; Ulrik Dalgas
Journal:  Sports Med       Date:  2021-04-16       Impact factor: 11.136

6.  Exercise rapidly alters proteomes in mice following spinal cord demyelination.

Authors:  Brian Mark Lozinski; Luiz Gustavo Nogueira de Almeida; Claudia Silva; Yifei Dong; Dennis Brown; Sameeksha Chopra; V Wee Yong; Antoine Dufour
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

7.  Case Report: Concurrent Resistance and Aerobic Training Regulate Adiponectin Expression and Disease Severity in Multiple Sclerosis: A Case Study.

Authors:  Elisa Grazioli; Ersilia Nigro; Claudia Cerulli; Giovanna Borriello; Annamaria Mancini; Eliana Tranchita; Rita Polito; Attilio Parisi; Pasqualina Buono; Aurora Daniele
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 4.677

8.  Effect of a Combined Program of Strength and Dual Cognitive-Motor Tasks in Multiple Sclerosis Subjects.

Authors:  Carmen Gutiérrez-Cruz; F Javier Rojas-Ruiz; Juan Carlos De la Cruz-Márquez; Marcos Gutiérrez-Dávila
Journal:  Int J Environ Res Public Health       Date:  2020-09-02       Impact factor: 3.390

9.  Finding the right balance with participation in exercise and sport for individuals with multiple sclerosis: protocol for a pre and post intervention feasibility study.

Authors:  Moira Smith; Gavin Williams; Ruth Barker
Journal:  BMJ Open       Date:  2020-03-18       Impact factor: 2.692

10.  Impact of aerobic exercise on clinical and magnetic resonance imaging biomarkers in persons with multiple sclerosis: An exploratory randomized controlled trial.

Authors:  Lina Savšek; Tamara Stergar; Vojko Strojnik; Alojz Ihan; Aleš Koren; Žiga Špiclin; Saša Šega Jazbec
Journal:  J Rehabil Med       Date:  2021-04-01       Impact factor: 2.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.